Rethinking Psychiatric Drugs: A Guide for Informed Consent

This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.

Are patients aware of the fact that pharmacological therapies stress the brain in ways which may prevent or postpone symptomatic and functional recovery? Rethinking Psychiatric Drugs: A Guide for Informed Consent is a critical appraisal of the medications which an estimated 20 per cent of Americans consume on a regular (and sometimes involuntary) basis. It is the philosophically, epidemiologically, and scientifically supported revelation of how and why psychiatry’s drug therapies have contributed to a standard of care which frequently does more to harm than to cure. Extensively researched and documented, the book addresses: the process by which psychiatric drugs reach the market; the history and philosophy of Evidence Based Medicine; the common flaws in research methodologies which negate the validity of the psychiatric RCT (Randomized Controlled Trial); the problem of allostatic load (how drugs stress the body); the history, long term effects, and utility of the drugs used to suppress symptoms of depression, psychosis, inattention and hyperactivity; and the effectiveness of alternatives to medication.
Rethinking Psychiatric Drugs: A Guide for Informed Consent exposes the current crisis in medical ethics and epistemology, and attempts to restore to psychiatry an authentically informed consent to care.